⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,838.95
−0.21%
FTSE ADX
9,858.92
+0.77%
TASI
9,981.33
−1.41%
QE Index
8,575.12
−0.67%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,854.48
−0.07%
DFM:EMIRATESNBD
AED 31.48
−0.06%
ADX:IHC
AED 360.00
+2.27%
SAU:2222
SAR 25.72
−0.31%
DSMD:QNBK
QAR 15.49
−1.09%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.15
+0.23%
Gold
$4,126.74
−0.34%
Brent
$110.43
+1.11%
BTC
$81,481.31
−0.44%
ETH
$2,389.55
−0.65%
DFM General
5,838.95
−0.21%
FTSE ADX
9,858.92
+0.77%
TASI
9,981.33
−1.41%
QE Index
8,575.12
−0.67%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,854.48
−0.07%
DFM:EMIRATESNBD
AED 31.48
−0.06%
ADX:IHC
AED 360.00
+2.27%
SAU:2222
SAR 25.72
−0.31%
DSMD:QNBK
QAR 15.49
−1.09%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.15
+0.23%
Gold
$4,126.74
−0.34%
Brent
$110.43
+1.11%
BTC
$81,481.31
−0.44%
ETH
$2,389.55
−0.65%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Open
🇶🇦
Qatar
QSE · QE General
Open
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
AbbVie Inc · News · TradingHolo
Markets
›
United States
› NYSE
› ABBV
A
AbbVie Inc
NYSE:ABBV
Healthcare
CBOE:SPESG
NASDAQ:NQUSLG
$282.68
−0.96%
At close
At close · Tue 20 Oct · ≈
AED 1,038.14
· Market cap
$499.53B
· Next earnings
Fri 30 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
ABBV news
Headlines tagged to this company
SE
Merck succeeds in mid-stage trial for skin disease drug
Seeking Alpha · 20 d ago
RE
Major drugmakers turn to China for licensing deals
Reuters · 20 d ago
SE
AbbVie's ABBV-295 delivers up to 9.8% weight loss in Phase 1
Seeking Alpha · 20 d ago
TR
Key facts: Juvmo +1.7 hrs controlled; AbbVie (ABBV) partners Valkai AI
TradingView · 20 d ago
DP
AbbVIe's Zumilokibart Meets Phase 2 Goal In Atopic Dermatitis Study
dpa-AFX · 20 d ago
SE
AbbVie reports positive phase 2 data for Zumilokibart in atopic dermatitis
Seeking Alpha · 20 d ago
GU
AbbVie Stock Drops Although Juvmo Wins Parkinson's Approval
GuruFocus · 21 d ago
DP
AbbVie Partners With Valkai To Advance AI-powered Clinical Research
dpa-AFX · 21 d ago
RE
Pharma sector doubles down on AI to slash costs, timelines
Reuters · 21 d ago
TR
AbbVie Inc. (ABBV) Partners With Valkai to Apply AI in Clinical Development
TradingView · 21 d ago
PR
AbbVie Partners with Valkai to Apply Advanced AI Across Targeted Areas of Clinical Development
PR Newswire · 21 d ago
GU
AbbVie Just Won an FDA First in Parkinson's Disease
GuruFocus · 22 d ago
RE
US drugmakers turn to China for licensing deals
Reuters · 22 d ago
DO
AbbVie Gets FDA OK of Juvmo for Parkinson's Disease
Dow Jones Newswires · 22 d ago
DP
AbbVie Announces FDA Approval Of JUVMO For Parkinson's Disease
dpa-AFX · 22 d ago
SE
AbbVie’s Juvmo wins FDA approval for Parkinson’s disease
Seeking Alpha · 22 d ago
PR
U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's Disease
PR Newswire · 22 d ago
TR
AbbVie Inc. (ABBV) Wins FDA Approval For JUVMO In Parkinson's
TradingView · 22 d ago
PR
U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's Disease
PR Newswire · 22 d ago
← Previous
More news →